Terumo’s WEB Device Marks 15 Years of Innovation Amid Stock Volatility
Terumo’s WEB device celebrates 15 years of revolutionizing aneurysm treatment, but its stock price suggests a company struggling to find its footing.
2 minutes to read
Interventional Neuroradiology Market Poised for Growth Amid Rising Neurological Disorder Cases
The global interventional neuroradiology market is expected to experience significant growth due to increasing prevalence of neurological disorders and demand for minimally invasive treatments.
One minute to read
Terumo Reports Strong Financial Results Amid Monopoly Concerns Over Cardiovascular Practices
Terumo has reported strong financial results, but its cardiovascular division is facing concerns over allegations of monopolizing medical equipment repair.
One minute to read
Terumo Cardiovascular Criticized for Restricting Repair Information Access
Terumo Cardiovascular is facing criticism for limiting access to repair information for its medical equipment, sparking concerns about monopolies and potential impacts on patients and healthcare providers.
One minute to read
Terumo’s Neurovascular Innovations: Genius or Risk?
Terumo’s neurovascular ambitions are making waves in the industry, but the company’s stock price and financials raise questions about whether its growth momentum can be sustained.
One minute to read